Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Sullivan

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Drug and Alcohol Dependence|August 28, 2012
Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurementAbigail J Herron, John J Mariani, Martina Pavlicova, et al.
Drug and Alcohol Dependence|August 8, 2007
Management of relapse in naltrexone maintenance for heroin dependenceMaria A Sullivan, Fatima Garawi, Adam Bisaga, et al.
Drug and Alcohol Dependence|July 19, 2015
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Behavioural Pharmacology|April 13, 2012
Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteersZiva D Cooper, Maria A Sullivan, Suzanne K Vosburg, et al.
The American Journal on Addictions|March 17, 2007
Socially sanctioned coercion mechanisms for addiction treatmentEdgar P Nace, Florian Birkmayer, Maria A Sullivan, et al.
Drug and Alcohol Dependence|December 30, 2015
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
Addiction (Abingdon, England)|September 24, 2011
Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public healthPerrine Roux, Claudia Tindall, Lionel Fugon, et al.
Addiction Biology|May 16, 2015
The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteersZiva D Cooper, Kirk W Johnson, Martina Pavlicova, et al.
The American Journal on Addictions|May 13, 2025
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate-to-severe alcohol use disorderRegina Grebla, Teresa L Kauf, Angela Lax, et al.
Behavioural Pharmacology|July 11, 2013
Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addictsSandra D Comer, Verena E Metz, Ziva D Cooper, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Drug and Alcohol Dependence|August 28, 2012
Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurementAbigail J Herron, John J Mariani, Martina Pavlicova, et al.
Drug and Alcohol Dependence|August 8, 2007
Management of relapse in naltrexone maintenance for heroin dependenceMaria A Sullivan, Fatima Garawi, Adam Bisaga, et al.
Drug and Alcohol Dependence|July 19, 2015
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Behavioural Pharmacology|April 13, 2012
Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteersZiva D Cooper, Maria A Sullivan, Suzanne K Vosburg, et al.
The American Journal on Addictions|March 17, 2007
Socially sanctioned coercion mechanisms for addiction treatmentEdgar P Nace, Florian Birkmayer, Maria A Sullivan, et al.
Drug and Alcohol Dependence|December 30, 2015
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
Addiction (Abingdon, England)|September 24, 2011
Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public healthPerrine Roux, Claudia Tindall, Lionel Fugon, et al.
Addiction Biology|May 16, 2015
The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteersZiva D Cooper, Kirk W Johnson, Martina Pavlicova, et al.
The American Journal on Addictions|May 13, 2025
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate-to-severe alcohol use disorderRegina Grebla, Teresa L Kauf, Angela Lax, et al.
Behavioural Pharmacology|July 11, 2013
Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addictsSandra D Comer, Verena E Metz, Ziva D Cooper, et al.
Pageof 9